Pharmacokinetics, Pharmacodynamics, and Safety of Nipocalimab in Healthy Chinese Volunteers: A Single-Dose, Phase I Study

Authors

Institutions

Publication Details

Journal
Neurology and Therapy
Published
2025-05-19
DOI
https://doi.org/10.1007/s40120-025-00763-5
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacokinetics, Pharmacodynamics, and Safety of Nipocalimab in Healthy Chinese Volunteers: A Single-Dose, Phase I Study

Jing‐yao Liu, L Zhang, Haiyan Li, Xiaohong Wang et al.
1 links
Neurology and Therapy
Monoclonal and Polyclonal Antibodies Research
article

Pharmacokinetics, Pharmacodynamics, and Safety of Nipocalimab in Healthy Chinese Volunteers: A Single-Dose, Phase I Study

Jing‐yao Liu, L Zhang, Haiyan Li, Xiaohong Wang, Weilong Zhao, Juanfang Liu, Xiaoye Niu, Zhongqi Dong
article en

Abstract

No abstract available for this paper.
Neurology and TherapyVol. 14(4)
Peking University (CN), Johnson Electric (China) (CN), Peking University Third Hospital (CN)
Zero hunger
Openalex Percentile: Top 84%
Monoclonal and Polyclonal Antibodies Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pharmacokinetics, Pharmacodynamics, and Safety of Nipocalimab in Healthy Chinese Volunteers: A Single-Dose, Phase I Study — Jing‐yao Liu, L Zhang, et al. · Neurology and Therapy (2025) | TGRS Research Map | TGRS